Skip to main contentSkip to navigationSkip to navigation
Chinese students in a university library
University libraries in developing countries struggle to pay fees for bundled access to Genomics and other Elsevier journals. Photograph: Graham Turner/Guardian
University libraries in developing countries struggle to pay fees for bundled access to Genomics and other Elsevier journals. Photograph: Graham Turner/Guardian

I can no longer work for a system that puts profit over access to research

This article is more than 11 years old
The associate editor of Genomics says its publisher Elsevier effectively denies developing world access to research findings

Today I resigned from the editorial board of a well respected journal in my field – Genomics. No longer can I work for a system that provides solid profits for the publisher while effectively denying colleagues in developing countries access to research findings.

It has not been an easy decision. Some may feel that I'm grandstanding or making a futile gesture. And it may be a toxic career move. Scientists are expected to contribute to the community by reviewing papers and serving on editorial boards. But I cannot stand by any longer while access to scientific resources is restricted.

My work on biomedical research in developing countries has shown me that lack of access to current publications has a severe impact.

The vast majority of biomedical scientists in Africa attempt to perform globally competitive research without up-to-date access to the wealth of biomedical literature taken for granted at western institutions. In Africa, your university may have subscriptions to only a handful of scientific journals.

In reality, the modus operandi is "please can you send me a pdf". Alternatively some researchers spend part of their research grant to buy a subscription to the journal they need.

I know this well, as this was what I did for 10 years while at Africa's sixth-ranked university in my native South Africa – the University of Western Cape. Unlike colleagues in developed countries with access to well-stocked libraries and online subscriptions, I have requested pdf articles from Elsevier, and other for-profit publishers, many, many times.

The open access movement in science represents a wind of change – or at least the promise of one.

As associate editor at Genomics, I have managed, reviewed and edited many manuscripts. The majority now come from China. I do not know how accessible the Elsevier journal Genomics is in Chinese universities, but I do know that institutions worldwide pay significant and frequently insurmountable fees for bundled access to this, and the publisher's other journals. It seems unfair to edit and review articles from scientists who will likely never see their work in the actual journal in which it is published.

So I'd prefer to devote the limited time I have available to an open access journal that provides its work at no cost to researchers who urgently require its contents to improve their environment.

Winston Hide is associate professor of bioinformatics and computational biology in the Department of Biostatistics at Harvard School of Public Health, where he specialises in the bioinformatics of genomic approaches to public health

More on this story

More on this story

  • Open access is the future of academic publishing, says Finch report

  • US petition could tip the scales in favour of open access publishing

  • Open access to research is inevitable, says Nature editor-in-chief

  • Attacking publishers will not make open access any more sustainable

  • Life after Elsevier: making open access to scientific knowledge a reality

  • Open access publishing should not favour those with deep pockets

  • Wikipedia founder to help in government's research scheme

  • Text mining: what do publishers have against this hi-tech research tool?

  • Open, free access to academic research? This will be a seismic shift

  • Harvard University says it can't afford journal publishers' prices

Comments (…)

Sign in or create your Guardian account to join the discussion

Most viewed

Most viewed